Fresenius Medical Care Sees US Plans for Kidney Disease as Positive
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Fresenius Medical Care has been at the forefront of dialysis technology, providing nephrologists the solutions to allow for the continuous enhancement of dialysis treatment. Today, over 90 percent of the machines used in the provision of hemodialysis are manufactured by Fresenius Medical Care.
Take a look and you’ll see why over 120,000 machines have been installed throughout the United States.
1. MP Rubin, PP Cody, RP Eisinger. “Amelioration of Hemodialysis-Associated Hypotension by the Use of Cool Dialysate.” Am J Kidney Disease 5 no. 2 (1985):124-127.
Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.
Note: Read the Instructions for Use for safe and proper use of these devices. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling.
© 2013, 2018-2019, Fresenius Medical Care, All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, 2008, 2008K@home, BlueStar, bibag, DIASAFE, Crit-Line, CLiC, and Clinical Data eXchange (CDX) are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. Citrasate is a registered trademark of Advanced Renal Technologies, Inc. in the United States and is used under license from Advanced Renal Technologies. All other trademarks are the property of their respective owners. P/N 100864-01 Rev B 07/2019